
|Articles|August 1, 2007
An Inspiration for Expiration Dates
Our office has devised a system to reduce the number of expired drug samples that must be discarded. We store all drug samples according to their expiry dates, with 1 shelf for each of the upcoming 12 months and a 13th shelf for samples that expire after 1 year.
Advertisement
Our office has devised a system to reduce the number of expired drug samples that must be discarded. We store all drug samples according to their expiry dates, with 1 shelf for each of the upcoming 12 months and a 13th shelf for samples that expire after 1 year. At the end of each month, we discard all remaining samples on that month's shelf; each quarter, samples on the 13th shelf are reclassified.
---- Sarla Maheshwari, MA and G. Lohiya, MD
Santa Ana, Calif
Advertisement
Related to this article

Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood screening test.

FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while reducing monitoring needs and highlighting weight risks.

The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.

FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.

Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.

EASD 2026: Oral semaglutide users lost 4.1% of body weight 3 months after switching from injections in an observational study without a comparator group.

Real-world phase 4 data show fezolinetant eases menopausal hot flashes and improves sleep, cutting nighttime awakenings by 2.6 by week 12.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia
2
Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
3
Real-World Nonhormonal Therapy Effects on VMS Bother, Work, and Mood
4
Abbott Gains FDA Approval for CardioMEMS Update Letting Heart Failure Patients View Pressure Readings on Their Phones
5
